All posts by imreal

Stay Active and Relieve Knee Pain with Hempvana’s Newest Product ‘Knee Bird’


The newest product from America’s number one pain relief brand, Hempvana, is out with a new product to target and tackle the number two type of chronic pain in the country: knee pain. More than a quarter of adults in the U.S. suffer from chronic pain in one or both of their knees, and millions more suffer from occasional pain. Hempvana’s Knee Bird patch is made to stay on all day and deliver long-lasting pain relief.

The Knee Bird uses Hempvana’s CoolNumb two-step pain relief technology. Menthol works right away to freeze the pain the moment the patch is applied. Then, lidocaine kicks in, numbing the pain. The ingredients penetrate muscles deeply for up to 8 hours of relief.

Unlike other pain patches, the Knee Bird is designed with movement in mind. The patch is shaped to fit perfectly under and around the kneecap, using flexible and bendable materials. Featuring an advanced adhesive formula, the Knee Bird will stay in place throughout even the most active days.

The Knee Bird patch works through long work hours and weekly grocery trips, punishing commutes, and walks through the park, so chronic pain doesn’t stop you in your tracks. Hempvana has been creating innovative products using a blend of FDA-approved, high-quality ingredients with natural remedies since 2018. Check out their entire pain relief line.

###

About Hempvana: Hempvana is a US-based, family-run company founded in 2018. Following their belief in marrying nature and science, Hempvana combines the benefits of plants with known active ingredients listed by the FDA. They do not believe anyone should have to compromise when it comes to pain relief. After multiple iterations of product formulas, testing, and trials, Hempvana is confident in its premium line of pain relief products. So start enjoying life again – without pain. Check out Hempvana’s site for additional information and to check out and purchase their diverse line of pain relief products for yourself.

ACTIVE INGREDIENTS:

Lidocaine (4%) ——– Topical Anesthetic

Menthol (1%)    ——– Topical Anesthetic

INACTIVE INGREDIENTS:

Aluminum Glycinate, Carboxymethylcellulose Sodium, Purified Water, Tartaric acid, Povidone, lodopropynyl Butylcarbamate, Phenoxyethanol, 3-(2-ethylhexyloxy)propane-1,2-diol, Glycerin, Sodium Polyacrylate, Polysorbate 80, Kaolin, Titanium Dioxide, Propylene glycol, Cannabis Sativa (Hemp) seed oil, Polyacrylic acid, Petrolatum

Share article on social media or email:

MedStar Health Receives Sandy Spring Bank Donation to Expand Cancer Care Services


News Image

We are deeply grateful to Sandy Spring Bank for this life-changing philanthropic investment to support our patients and community, and for the wonderful partnership we have enjoyed with the bank throughout the years.

MedStar Health, today announced a $250,000 philanthropic gift from long-time community partner Sandy Spring Bank to expand cancer care services at MedStar Montgomery Medical Center. The gift will be used toward the development of the Oncology Pavilion at MedStar Montgomery to house oncology services such as chemotherapy, immunotherapy, radiation, and other treatment and support services.

Sandy Spring Bank’s support of MedStar Montgomery dates back to the founding of the then Montgomery General Hospital in the early 1900s and has continued for more than 100 years through various community, philanthropic, and volunteer support initiatives.

“We are deeply grateful to Sandy Spring Bank for this life-changing philanthropic investment to support our patients and community, and for the wonderful partnership we have enjoyed with the bank throughout the years. With this gift, we will expand access to our world-class team of experienced oncologists, surgeons, researchers, specialists, and support cancer care services,” said Thomas J. Senker, FACHE, President of MedStar Montgomery Medical Center.

Upon completion, the Oncology Pavilion will optimize coordination of patient care, enhance effective communication between providers, decrease length of time between medically necessary “day-of” services, increase patient care capacity, improve wayfinding, and more.

“Sandy Spring Bank has supported MedStar Montgomery Medical Center since the hospital was founded over 100 years ago. Through our philanthropic gift toward the Oncology Pavilion, we will help the hospital expand the Cancer Center, improve the patient experience, and achieve another milestone in its storied history,” said Daniel J. Schrider, President and CEO of Sandy Spring Bank. “Our organizations have been pillars in the community for over a century, and this gift is our way of showing our appreciation for our original, hometown hospital.”

About MedStar Montgomery Medical Center and MedStar Health

MedStar Montgomery Medical Center is a not-for-profit, acute care community hospital serving Montgomery County, Maryland. For 100 years, MedStar Montgomery has served as a medical care provider and community health resource offering high-quality, personalized care. MedStar Montgomery provides a broad range of healthcare specialties, advanced technologies, and treatments not traditionally found at community hospitals—including cutting-edge care in obstetrics, orthopedics, breast health, and oncology. MedStar Health is the region’s largest non-profit and most trusted integrated healthcare delivery system, giving patients access to the latest in modern medicine and medical technology within a community hospital setting.

About Sandy Spring Bank

Sandy Spring Bancorp, Inc., headquartered in Olney, Maryland, is the holding company for Sandy Spring Bank, a premier community bank in the Greater Washington, D.C. region. With over 50 locations, the bank offers a broad range of commercial and retail banking, mortgage, private banking, and trust services throughout Maryland, Virginia, and Washington, D.C. Through its subsidiaries, Rembert Pendleton Jackson and West Financial Services, Inc., Sandy Spring Bank also offers a comprehensive menu of wealth management services.

Share article on social media or email:

Keychron launches Q8: Alice-style custom mechanical keyboard


News Image

At Keychron we’re all about typing comfort, so it was important for us to add an Alice-style keyboard to our offering. This layout appeals to many typists because it allows them to angle their hands and wrists in a more natural position.

Today Keychron, established manufacturer of wireless mechanical keyboards for Mac, Windows and Android, launched direct sales of Q8 on the brand’s website. This model is a full aluminum mechanical keyboard in the visually striking, ergo style 65% Alice layout. Four versions are available: barebone is $175 USD, barebone knob is $185 USD, fully assembled is $195 USD, and fully assembled knob is $205 USD.

“Wrists can be angled unnaturally on traditional keyboards causing strain on muscles and a host of issues for typists,” said Paul Tan, COO of Keychron. “At Keychron we’re all about typing comfort, so it was important for us to add an Alice-style keyboard to our offering. This layout appeals to many typists because it has a space that visually separates the board into two halves with the keys extending outwards in a wingspan-shaped form allowing users to angle their hands and wrists in a more natural position.”

With its all-metal CNC machined body, a full-size layout, double-gasket design, QMK/VIA support, south-facing RGB, and knob option, the Q8 meets practical needs and provides a high-end typing experience. The entire metal body is crafted with 6063 aluminum that is processed through CNC machine, polished, anodized, sandblasted, and undergoes 24 more manufacturing stages to make the solid metal piece of art that is the Q8. A brand new ultra-low-power MCU Arm structure is armed with 128K Flash to provide more flexibility for developers. The polling rate is up to 1000 Hz out of the box, which makes latency non-existent for the competitive gamer.

“We designed every component of Q8 to be easily assembled, so users can adjust the keyboard to their needs,” continued Tan. “The premium rotary encoder allows users to easily customize their favorite keys and macros on the knob through the VIA software such as: zooming in/out, adjusting screen brightness, brush size, volume, and selecting video clips or photos. The open-source firmware means endless possibilities for keyboard layouts, shortcuts, backlight effects, and more.”

The Double Gasket Design is a new innovative structure in the industry. In addition to the gaskets on the plates, Keychron added silicone pads between the top and bottom cases to significantly reduce the sound resonance between the metals and reduce the noise of the impacted metals. This design allows the keyboard to maintain the flexibility of the gasket structure and improves the overall typing sound.

For the new double-shot PBT keycaps, Keychron built a new profile called the OSA (OEM spherical angled) keycap. It has a similar height to the OEM profile and has an SA-like shape. The PBT keycaps provide excellent oil resistance, enhance the type feel, and prevent the legends from fading out.

The hot-swappable sockets are mounted on the PCB, so users can install or change the switches without soldering. The PCB supports both three- and five-pin MX mechanical switches. The optimized molded switch with more precise positioning and less wobble will undoubtedly improve the feel at the user’s fingertips. With the fully assembled Q8 version fitted with factory pre-lubricated Gateron G Pro switches providing a smoother travel experience. The screw-in design increases stability and makes it easier for changes and upgrades.

Built with the Mac users’ experience in mind while still retaining compatibility for Windows devices, the Keychron Q8 comes with a system toggle and an additional set of customized keycaps for both Windows and macOS systems. Users can now save two different layouts on the keyboard, one for each system.

Media wishing to interview Keychron personnel should contact PR agent Borjana Slipicevic at borjana@properpropaganda.net

About Keychron

Keychron was formed in 2017 by a group of keyboard enthusiasts, designers, marketers, and production experts. The founding team members, Will Ye and Sven Zhu have a combined 20 years of experience in keyboard production and industrial design. They’ve dedicated themselves to creating the most sophisticated mechanical keyboards with minimalist design. To date, the team has successfully launched and fulfilled 20 mechanical keyboards to customers in 80 countries.

Share article on social media or email:

Health care sector has a critical role to play in mitigating harm to sexual and gender minorities caused by policies that limit access to care


Fenway Health logo, blue box with white text

From Texas to Florida, lawmakers are enacting policies and laws that put sexual and gender minorities at great risk of harm.

A Perspective essay published July 23, 2022 in the New England Journal of Medicine provides guidance on how the health care sector can mitigate the harm to sexual and gender minorities (SGM) caused by recently enacted and proposed legislation that limit access to care. The “Triple Aim framework” offered by the authors of the Perspective outlines a process by which providers, payers, researchers, and policymakers can enhance SGM patients’ care experiences, improve population health, and reduce per capita costs of care.

“From Texas to Florida, lawmakers are enacting policies and laws that put sexual and gender minorities at great risk of harm,” said senior author Dr. Alex S. Keuroghlian, who directs the National LGBTQIA+ Health Education Center at The Fenway Institute and the Massachusetts General Hospital Psychiatry Gender Identity Program. “Leaders from all sectors of health care have a responsibility to enact new ways of providing care, collecting data, and designing systems that support health equity and protects the health of sexual and gender minorities.”

A national survey of transgender people found that nearly one-quarter (23%) reported that they avoided necessary health care for fear of mistreatment by providers. Rates of health care avoidance were higher among transgender people who were also members of marginalized racial and ethnic groups, demonstrating the intersectional burdens of transphobia and racism.

“Policies that cast sexual and gender minority people as outsiders, whose identities should not be discussed and whose health care is criminalized, are doubly damaging to populations that already experience substantial health inequities,” said co-lead author and Harvard Medical School student Michael Liu, M.Phil. “First, they directly limit access to lifesaving, evidence-based health care. Second, they exacerbate minority stressors such as employment discrimination, peer violence, and internalized oppression that are associated with belonging to marginalized groups and that are known to worsen physical and mental health in these populations.”

The Triple Aim framework offers meaningful and actionable steps to support data collection, financing models, workforce development, and social protections to improve health among SGM people:


  • Collect additional standardized data to inform the development of quality-improvement, research, and policy initiatives that will protect the health of SGM people.
  • Require sexual orientation and gender identity (SOGI) data collection as part of federal payment and quality-reporting programs.
  • Link rates of payment to equity measures such as reporting on and reducing SGM health disparities.
  • Design and implement workforce development efforts to support the specific needs of SGM patients. Such efforts could include education and training in medical schools and professional development and learning for clinicians.
  • Advocate against harmful legislation and in favor of protective policies by physicians and medical professional organizations.
  • Research the health impacts of anti-SGM legislation and the potential benefits of protective policies and interventions.

“Medical providers have a responsibility to be familiar with the most up-to-date scientific and clinical information related to SGM people,” said co-lead author and Harvard Medical School student Sahil Sandhu, M.Sc. “But increased efforts by policymakers, legislators, and other public leaders to harm the health of SGM people by limiting their access to care is a call to the health care sector to rededicate itself to providing quality care experiences and improving health outcomes for people of all sexual orientations and gender identities.”

“Achieving the Triple Aim for Sexual and Gender Minorities” was published July 23, 2022 by the New England Journal of Medicine and is available online here.

Share article on social media or email:

ZeptoMetrix® Launches NATtrol™ Bacteriophage MS2 Quantitative Stock Solution


ZeptoMetrix Quality Controls

ZeptoMetrix NATtrol™ Bacteriophage MS2 quantitative stock: NATMS2-STQ is intended for use as an internal process control for molecular diagnostic assays.

The addition of the NATtrol MS2 is another great example of our commitment to the MDx industry.

ZeptoMetrix®, an Antylia Scientific™ company, today launches the NATtrol™ Bacteriophage MS2 quantitative stock: NATMS2-STQ. This product is intended for use as an internal process control for molecular diagnostic assays.

Bacteriophage MS2 is a virus that infects Escherichia coli bacteria and other members of the Enterobacteria family. It has proven utility as an internal process control for rt-PCR assays. NATtrol inactivation of MS2 results in a refrigerator-stable, whole organism stock solution which shows increased reproducibility and lot-to-lot consistency over live MS2, making it an ideal internal control for rt-PCR assays.

“The combination of our dedicated scientific consulting team and our innovative materials for assay development make ZeptoMetrix the partner of choice for molecular diagnostics developers,” said Evangeline Gonzalez, Vice President/General Manager of ZeptoMetrix. “The addition of the NATtrol MS2 is another great example of our commitment to the MDx industry.”

Find more information on the NATtrol Bacteriophage MS2 Quantitative Stock and additional ZeptoMetrix products at http://www.zeptometrix.com.

About ZeptoMetrix

ZeptoMetrix, an Antylia Scientific company, is an established industry leader in the design, development, and delivery of innovative, quality solutions to the infectious disease diagnostics market. Our expertise and abilities in molecular diagnostics, including external quality controls, verification panels, proficiency panels, customized and OEM products/services have set the industry standard for performance and reliability and make ZeptoMetrix the preferred choice for independent third-party quality control materials.                                                            

#####

Share article on social media or email:

capracare Haiti Announces “Honoring Courage” Charity Benefit


Haitian Charity Organizations

Since its inception, capracare has sheltered hundreds and provided emergency relief to thousands.

“It is crucial that capracare continues its mission and commitment to the people of Haiti who are still recovering from this catastrophic earthquake. I am immensely grateful to our supporters who made it possible for us to do what we do,” says Jean Pierre—Louis, President & CEO of capracare.

capracare, a trusted community organization whose humanitarian efforts relieved over 20,000 people in need during the 2021 Haiti earthquake, today announced its inaugural “Honoring Courage” charity benefit. The in-person event will commence on Sunday, August 7, 2022, at New York Mets’ Clubhouse, Citi Field, 123-01 Roosevelt Ave, Queens, NY 11368; at 2:30 pm EST. Honoring Courage will celebrate the Haitian people and the many New Yorkers who demonstrated incredible courage in the wake of the 2021 Haiti earthquake.

The 7.2 magnitude earthquake struck the southern peninsula of Haiti and left, thousands injured or dead. In addition, many hospitals, schools, and homes were destroyed, leaving the people of Fonfrède and the greater Les Cayes homeless.

Without haste, elected officials from around the world and fellow New Yorkers showed an outpouring support to provide capracare with the resources needed to deploy emergency relief, medical and mental health support to the region through mobile units.

“It is crucial that capracare continues its mission and commitment to the people of Haiti who are still recovering from this catastrophic earthquake. I am immensely grateful to our supporters who made it possible for us to do what we do,” says Jean Pierre—Louis, President & CEO of capracare.

The Honoring Courage charity event will be supported by capracare’s most prominent visionaries– all of whom embody the driven and generous spirit championed through capracare’s programs. In addition, the New York Mets will honor capracare in a special on-field pregame when they take on the Atlanta Braves. As part of the pregame ceremony, the United Jewish Appeal– Federation of New York (UJA) will be recognized for its commitment to the Haitian people and capracare’s mission. capracare Ambassadors, Maxine Cesar, Miss Grand New York 2022, and singer/songwriter Demi Dabady will emcee the event.

Your support of this event will help capracare continue delivering crucial relief to Haitian communities still recovering from the southern Haiti earthquake. capracare’s goals are to raise awareness, foster continued action, and raise funds to improve the livelihoods across the southern region of Haiti.

capracare’s supporters of the event include Kvon Folo, Pascal DuBois, Forest Hills Stadium, Gentlemen’s Factory, EVS Health Services LLC, HABNET Chamber of Commerce, Trendy Tripping, and Apples & Oranges Public Relations.

To attend and/or support capracare’s “Honoring Courage” benefit, visit https://www.capracare.org/. For media inquiries and more info, please contact Sara Vannucci at sara.vannucci@capracare.org. To learn more about sponsorship opportunities please click here. Connect on Twitter, Facebook, Instagram, YouTube, and TikTok.

About capracare

Founded in 2009, capracare has established itself as a trusted community health resource. The organization mobilizes the global humanitarian community to provide primary and preventative care, mobile health clinics, mental health counseling, education, and emergency relief to people in Fonfrède and the greater Les Cayes area. capracare, Inc. is a registered 501c3. | EIN 01-0973544 | P.O. Box 1408, New York, NY 10276

Share article on social media or email:



AURA Devices Sponsors Two Track & Field Athletes at World Athletic Championship Oregon22


Rai Benjamin & Aleia Hobbs

“We couldn’t be more thrilled than to have Rai and Aleia using our newest product, the AURA Strap 2, to help them get in shape to compete at events like the World Athletics Championships and Olympic Games,” said Stas Gorbunov, CEO of AURA Devices.

Technology is transforming the sports industry. For athletes, many are increasing their potential by using wearable solutions to help them train and compete. AURA Devices, makers of wearable devices to monitor health, wellness, and activity, are proud to announce that track and field athletes Rai Benjamin and Aleia Hobbs, who were competing in the World Athletics Championships Oregon22, use the new AURA Strap 2 as part of their training.

“We couldn’t be more thrilled than to have Rai and Aleia using our newest product, the AURA Strap 2, to help them get in shape to compete at events like the World Athletics Championships and Olympic Games, the world’s two most prestigious track and field events,” said Stas Gorbunov, CEO of AURA Devices.

Rai, the American Record Holder and Olympic silver medalist over 400m hurdles and Olympic Champion in the 4x400m relay, defended his silver medal in Oregon noted, “I am delighted to partner with a company like AURA Devices that helps me monitor my health in such great detail. Being able to track my workout performance and muscle and fat composition with AURA Strap 2 is paramount to increasing my performance.”

Aleia, an American sprinter specializing in the 100m, was the fastest American woman in the 100m final, taking sixth place at the World Championships and winning gold as part of the 4x100m USA Relay Team. According to Alexa, “it’s a tremendous honor to partner with AURA Devices as an ambassador, and I am very excited to work with them in improving my performance by tracking my workouts and analyze my body composition with AURA Strap 2.”

The AURA Strap 2 provides a new health and wellness data tracking experience by allowing users to set goals and track their workout performance on their Apple Watch. The wrist-wearable Apple Watch accessory takes hand-to-hand bioelectrical impedance (BIA) measurements to provide the user with information about body composition and water level.

By performing bioelectrical impedance analysis (BIA), which measures how a person’s body changes as a result of exercise, AURA Strap 2 is the only wearable device that provides fat, muscle, and water balance measurement on the Apple Watch. From there, via AURA App version 3.0, users receive insights, personalized recommendations, and goal setting and management functions to assist them in optimizing their fitness performance and achieving their goals.

Held for the first time in the United States, the World Athletics Championships Oregon22 features over 1,900 athletes from 192 national federations, including 37 defending world champions. The competition spans ten days from July 15-24 at historic Hayward Field on the campus of the University of Oregon for a celebration of diversity, human potential, and athletic achievement.

The AURA Strap 2 is available in black exclusively for Apple Watch, Series 3 or later. It retails for $149 and is available on auradevices.io.

About AURA Devices

Founded in 2016, AURA Devices develops and engineers’ products that make people happier and healthier. The company is led by a bold team of inventors developing mobile devices based on science to monitor health, wellness, and activity that help users to achieve their goals and change health perceptions. The team believes that every person should know everything about their health on-demand. The company is pushing the boundaries to change the healthcare and fitness world, combining technology with human effort. To learn more, visit AURA Devices.

Share article on social media or email:

ACCES I/O Products Announces a new line of powerful PCI Express Mini Card (mPCIe) and M.2 Multifunction Analog I/O Cards (26 COTS Models!) with Speeds up to 2MHz


AccesI/O Products, Inc.

ACCES I/O Products announces the immediate release of two new embedded PCI Express-based families of high performance and low-cost analog I/O cards – the mPCIe-AIO Family and the M.2-AIO Family. These innovative families of 16-bit and 12-bit ADC cards start with the flagship models, the mPCIe-AIO16-16FDS and the M.2- AIO16-16FDS (NVME compatible!).

ACCES’ mPCIe and M.2 high-speed, 16-bit multifunction analog input/output cards are ideal for precision measurement, analysis, monitoring, and control in countless embedded applications found in rugged or industrial environments. Each design can sample inputs at speeds up to 2Msps for the board’s 16 single-ended or 8 differential analog input channels (1MHz acquired simultaneously on each of two analog input paths). Standard features include four 16-bit analog outputs and two high-current digital I/O lines — all contained on the ultra-small mPCIe F1 or M.2 2260/2280 embedded form factors. Striking an excellent price/performance balance, these families also include models with slower A/D speeds, optional analog outputs, and lower performance 12-bit modules, for less demanding applications.

Each form factor offers over a dozen models with list prices ranging from only $299 to $839, an unprecedented value in such a small package. The cards feature seven software-selectable per-channel analog voltage input ranges, including 4-20mA current inputs (factory option). This channel-by-channel programmable gain feature enables measurement of an assortment of large and small signals in one scan—all under software control at up to 1MHz. Two simultaneously sampling ADCs provide unique benefits in multi-channel vibration and transient analysis, and the 4 kSample FIFO+DMA-driven data is optimum where high data rates must be sustained for short—or long— periods of time.

The four analog outputs each have five software selectable ranges and can drive up to 10mA. The flagship FDS models add hardware-paced 8 kSample FIFO+DMA-driven Streaming Waveform Playback on one, two, three, or all four DACs, at any aggregate rate up to 1Msps.

The two pulled-up digital I/O pins can be used independently as simple input or output, external ADC trigger, ADC start conversion, DAC trigger (LDAC), watchdog status output, and more!

The cards have been designed for use in harsh and rugged environments such as military and defense along with consumer/industrial applications such as medical, point of sale systems, kiosk design, retail, hospitality, automation, gaming and more.

Key features of the mPCIe-AIO and M.2-AIO Families include:


  • PCI Express Mini Card (mPCIe) Type F1 or M.2 Type B/M 2260/2280, with latching I/O connector
  • 2× 16-bit, bipolar, differential, A/D converters sampling at up to 1MHZ, simultaneously (2Msps)
  • Software selectable as 16+0, 8+4, or 0+8 (single-ended + differential inputs)
  • Seven channel-by-channel Programmable differential input ranges from ±0.3125V up to ±12V
  • A/D starts via software, external input, or periodic timer
  • A/D “scan start” mode optimizes inter-channel timing, reducing skew
  • High Impedance, 16-channel input: 500 MΩ
  • 4 kSample FIFO+DMA for efficient, robust data streaming
  • Two digital I/O with flexible secondary functions
  • Four 16-bit analog outputs with optional 8 kSample FIFO+DMA Waveform Streaming
  • 5 per-channel programmable ranges: 0-5V, 0-10V, ±2.5V, ±5V, ±10V
  • Outputs drive ±10mA
  • Onboard watchdog with status output
  • RoHS compliant standard

All ACCES mPCIe and M.2 cards offer high retention latching connectors for shock and vibration mitigation as well as an optional extended operating temperature of -40°C to +85°C. The small size (mPCIe Type F1: 30mm x 50.95mm and M.2 2260/2280: 22mm x 60mm/80mm) allows for maximum performance in applications where space is a valuable resource. The mPCIe form factor has proven itself over time and the newer M.2 form factor provides an even smaller footprint for embedded applications where compact size is critical. Both Families share the same register map and I/O pinout, making moving to either design a straightforward change. This M.2 card is compatible with standard NVME sockets, common on all modern motherboards.

Factory Options Include: Extended temperature, current inputs (4-20mA, 10-50mA), voltage dividers for higher voltage inputs. Additional customization options include conformal coating, custom software / product-labeling, and more — even entirely new features, enabled by our advanced FPGA-based design!

These cards are supported for use in most operating systems and include a free Linux and Windows compatible software package. This package contains sample programs and source code in C# and Delphi for Windows. Linux support includes installation files and samples for programming level via our open-source kernel driver. Third party support includes a Windows standard DLL API library usable from most popular application programs. Embedded OS support includes the family of Windows Operating Systems including IoT. ACCES also now offers a VxWorks driver/library for the ultimate real-time process monitoring and control solution.

About ACCES I/O Products, Inc. For over 30 years, ACCES I/O Products, Inc. has supplied an extensive range of analog, digital, serial communication, and isolated I/O boards and solutions. ACCES also offers complete systems, integration services and enclosures with a quick turn-around on custom projects including software. ACCES products are designed for use with mPCIe (PCI Express MiniCard), M.2, PCI Express, PCIe/104, Ethernet, USB, PCI, PC/104, and ISA, as well as distributed, wireless I/O, and computer-on-module (COM) form factors. All hardware comes with a 30-day, no-risk return policy and a three-year warranty. For further information, visit the company’s website at http://www.accesio.com.

Price: Prices range from $299 to $839. Please inquire for OEM and volume pricing.

Availability: Now

Delivery: Stock to two weeks ARO

Card Images and Product Information: https://accesio.com/m-2-and-pci-express-mini-card-mpcie-analog-multifunction-cards/

For Further Information, Contact:

Chris Persidok

Marketing Communications Director ACCES I/O Products, Inc. 10623 Roselle Street, San Diego, CA 92121-1506

Tel: 858.550.9559

E-mail: cpersidok@accesio.com

URL: http://www.accesio.com

Share article on social media or email:

Supporting Health Equity with Social Determinants of Health Data and Location Intelligence


Big data and machine learning tool to identify site recommendations for “pop-up” mobile vaccination clinics in Laredo, TX.

The goal in using big data and machine learning is to make new information visible that moves us beyond traditional delivery of health care and focuses on early public health interventions that make a difference in our communities and the people who live within them.

What if we could target public health interventions to quickly reach the people who needed them most? Data science company RS21 and the Wellness & Equity Alliance (WEA), a national organization of public health clinicians, are working to do just that. The focus is on closing gaps and achieving health equity using big data and machine learning to inform hyperlocal, targeted strategies.

“We’re bringing together novel data sets, like social determinants of health and location data, to improve health equity,” said Angelica Bruhnke, Health Lab Division President at RS21. “By understanding root causes, vulnerability gaps and other insights, we can help inform policy and planning to lower costs, remove barriers to care and improve wellbeing.”

Working with WEA, which received CDC funding aimed to improve health equity around COVID-19 clinical services, RS21 is blending location data and over 90 indicators for health and wellness to address disparities in access to care and resources. Going beyond the geospatial distribution of people and resources, RS21 is using data science and machine learning models to identify trends and correlations that are not otherwise apparent.

In-line with WEA’s mission to disrupt public health services by optimizing access to the most marginalized communities, the alliance began working with RS21 to pilot a site selection technique to place “pop-up” mobile vaccination clinics in Laredo, TX with the purpose of getting COVID-19 vaccines to the people most vulnerable to COVID-19 – namely asylum seekers and people living in Colonias (or unincorporated villages along the southern U.S. border with nearly 2 million inhabitants living in abject poverty).

“COVID-19 amplified the inequities in the health system that have existed for decades and predated on vulnerable public health systems that intended to protect the most marginalized communities in the U.S. After administering over 2 million COVID-19 vaccines in 10 states with a focus on communities lacking historical health care access, we believe that the private-public partnership is the future of public health,” said Tyler B. Evans, CEO and Co-Founder of WEA.

Leveraging the CDC’s Social Vulnerability Index (SVI), the RS21-developed Urban Health Vulnerability Index (UHVI) and data from the Texas Department of State Health, the team identified high-risk communities near the Laredo-Mexico border. They then added a location intelligence layer to estimate density and movement patterns to hone in on sites where “pop-up” mobile vaccination clinics would reach the most people.

“The goal in using big data and machine learning is to make new information visible that moves us beyond traditional delivery of health care and focuses on early public health interventions that make a difference in our communities and the people who live within them,” said Bruhnke.

RS21 and WEA are continuing to work together to identify additional opportunities to improve health equity with precision strategies and targeted public health programs – with additional pivots into other areas of formidable public health concern, namely substance use disorders.

About Wellness & Equity Alliance

Wellness & Equity Alliance (WEA) is a novel national public health organization comprised of a multidisciplinary team of clinicians, community health workers and population health experts with expertise in infectious disease, public health, emergency medicine, primary care, cardiology, pediatrics, psychiatry, community health work (CHW), nursing and advanced practice pharmacy. They work nearly exclusively with underrepresented communities, fundamentally addressing health-care disparities and the social determinants of health (SDoH) that have been amplified during the COVID-19 pandemic, prioritizing the following: people experiencing homelessness, indigenous communities, immigrant communities, rural communities, BIPoC communities, LGBTQ+ communities and justice-impacted communities. Visit https://www.wellnessequityalliance.com.

About RS21

RS21 is a rapidly growing data science company that uses artificial intelligence, design, data engineering, and modern software development methods to empower organizations to make data-driven decisions that positively impact the world. Our innovative solutions are insightful, intuitive, inspiring, and intellectually honest. With offices in Albuquerque, NM and Washington, DC, RS21 is an Inc. 5000 fastest-growing company and a Fast Company Best Workplace for Innovators.

We help clients achieve programmatic goals, improve efficiencies, reduce costs, and maximize productivity using MOTHR, our human-centered, artificial intelligence engine that allows users to seamlessly integrate data and reveal insights at hyper speed. We navigate complex data issues in the fields of healthcare, defense, safety, urban planning, energy, cyber, land use, climate, disaster preparedness, disaster recovery, space, and social equity. Visit http://www.rs21.io.

Share article on social media or email:

SkinIO brings access to skin cancer prevention to vulnerable patient population during COVID-19


News Image

SkinIO, an AI-driven, virtual skin screening platform, was used in a real-world study by Stanford School of Medicine’s Department of Dermatology with results just published in the Skin Health and Disease Journal. The purpose of the study was to pilot a new model of dermatologic care to overcome barriers for senior living communities during the COVID‐19 pandemic, including increased vulnerability to the virus, long quarantines for clinic visits, and difficulties with telemedicine adoption. All of which made elderly patients’ adherence to their annual in-person skin exams impossible.

“Elderly patients are at high risk of developing skin cancers and rely on skin screening exams for early skin cancer detection and treatment,” said Kyoko Crawford, Chief Executive Officer of SkinIO. “During the COVID-19 pandemic, it was unrealistic and unsafe for nursing home patients to leave quarantine for an in-person skin exam. So SkinIO safely brought full-body skin exams to them.”

Over the course of the 8-month study, non-physician clinical staff who tested negative for COVID-19 used the SkinIO mobile app-based system, installed on iPads, to do full-body photography of residents from the Sequoias Portola Valley Senior Living Retirement Community who opted into the study. SkinIO’s AI-driven deep learning analyzed patient images in real time and flagged suspicious outlier lesions for close-up dermoscopic photos. A dermatologist reviewed each patient’s photos remotely, then reviewed the photos with each patient and provided recommendations via a video visit.

Of the 27 nursing home residents who participated, 3 skin cancers were identified, 11 were scheduled for a follow-up visit, and 4 started home treatment.

“We were very excited by the patients’ reaction to the experience. 88% of patients reported that they were satisfied with the program, with 77% likely to recommend the program to others. 92% of patients agreed that the photographs were representative of their skin. And in the context of the COVID-19 pandemic, 100% of patients felt the process was safer or comparable to an in-person visit,” said Kavita Sarin, MD, PhD, associate professor of dermatology at the Stanford School of Medicine.

In addition to overall appreciation for the virtual program, more than a third of patients reported that they would prefer to see dermatologist in-person after the pandemic, further underscoring the opportunity for SkinIO to drive traffic and uptake for dermatologists on follow-up.

“We developed SkinIO with a mission to broaden access to lifesaving dermatology for both underserved and vulnerable populations,” said Crawford. “This study is an incredibly fulfilling example of the promise of SkinIO technology in action.”

The manuscript of the study is available here: https://onlinelibrary.wiley.com/doi/10.1002/ski2.141

ABOUT SkinIO

SkinIO is a HIPAA-compliant, AI-driven, virtual skin cancer screening platform that allows anyone, anywhere to perform a skin exam in just 10 minutes using their smartphone. SkinIO images are reviewed remotely by expert dermatologists, users receive their results by email in just a few days, and they are connected to care if they require in-person follow-up. For more information, visit skinio.com.

###

Share article on social media or email: